Exercise Training Attenuates Obesity-Induced Skeletal Muscle Remodeling and Mitochondria-Mediated Apoptosis in the Skeletal Muscle
Overview
Public Health
Authors
Affiliations
Obesity is characterized by the induction of skeletal muscle remodeling and mitochondria-mediated apoptosis. Exercise has been reported as a positive regulator of skeletal muscle remodeling and apoptosis. However, the effects of exercise on skeletal muscle remodeling and mitochondria-mediated apoptosis in obese skeletal muscles have not been clearly elucidated. Four-week-old C57BL/6 mice were randomly assigned into four groups: control (CON), control plus exercise (CON + EX), high-fat diet (HFD), and HFD plus exercise groups (HFD + EX). After obesity was induced by 20 weeks of 60% HFD feeding, treadmill exercise was performed for 12 weeks. Exercise ameliorated the obesity-induced increase in extramyocyte space and a decrease in the cross-sectional area of the skeletal muscle. In addition, it protected against increases in mitochondria-mediated apoptosis in obese skeletal muscles. These results suggest that exercise as a protective intervention plays an important role in regulating skeletal muscle structure and apoptosis in obese skeletal muscles.
The role of autoantibodies in bridging obesity, aging, and immunosenescence.
Valentino T, Chen N, Makhijani P, Khan S, Winer S, Revelo X Immun Ageing. 2024; 21(1):85.
PMID: 39616399 PMC: 11607830. DOI: 10.1186/s12979-024-00489-2.
Rejeki P, Pranoto A, Widiatmaja D, Utami D, Izzatunnisa N, Sugiharto Sports (Basel). 2024; 12(5).
PMID: 38786985 PMC: 11126026. DOI: 10.3390/sports12050116.
Proenca A, Alexandre-Santos B, Giori I, Alex-Marques J, Machado-Santos C, Machado M Physiol Rep. 2024; 12(9):e16025.
PMID: 38684378 PMC: 11058004. DOI: 10.14814/phy2.16025.
3D Mitochondrial Structure in Aging Human Skeletal Muscle: Insights into MFN-2 Mediated Changes.
Scudese E, Vue Z, Katti P, Marshall A, Demirci M, Vang L bioRxiv. 2024; .
PMID: 38168206 PMC: 10760012. DOI: 10.1101/2023.11.13.566502.
Understanding the development of sarcopenic obesity.
Gross D, Cheever C, Batsis J Expert Rev Endocrinol Metab. 2023; 18(6):469-488.
PMID: 37840295 PMC: 10842411. DOI: 10.1080/17446651.2023.2267672.